-
www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/hepatitis-c-virus-infection-screening-2004
March 08, 2004 - also found an independent association between HCV infection and high-risk sexual behaviors (variably defined … and clear their viremia (viremia load undetectable by PCR) or have a significant response (usually defined
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/We5A-uCMvX5qYeFukGgqks
March 01, 2004 - also found
an independent association between HCV infection
and high-risk sexual behaviors (variably defined … and clear their viremia (viremia load
undetectable by PCR) or have a significant response
(usually defined
-
digital.ahrq.gov/sites/default/files/docs/page/CFH_%20AHRQ-7-25-06_Final.ppt
August 01, 2006 - SNO: A SNO is any group of entities (regionally or non-regionally defined) that agree to communicate … SNO: A SNO is any group of entities (regionally or non-regionally defined) that agree to communicate
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/psychiatric-readmissions_disposition-comments.pdf
May 21, 2015 - , potentially
minimizing false positive results with respect to the population (such as it
can be defined … Some of the interventions, such as the
"computerized decision support tool" are not clearly defined.
-
digital.ahrq.gov/sites/default/files/docs/citation/cedar_environmental_scan.pdf
April 01, 2023 - How is “trustworthiness” defined in the context of searches conducted of the CEPI
repositories by the … 47
Well-established tool to
assess and certify data
repositories that meet
the 16 core criteria
defined
-
effectivehealthcare.ahrq.gov/sites/default/files/obesity-horizon-scan-high-impact-1506.pdf
June 01, 2015 - adults (about 78.6 million) and 17% of youth (about 12.7 million) in the United States are obese
(defined … If clinicians
determine drug therapy is safe and effective, defined as weight loss of 5% or greater
-
www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary/healthy-lifestyle-and-physical-activity-for-cvd-prevention-adults-without-known-risk-factors-behavioral-counseling
July 26, 2022 - significant differences between intervention and comparison groups for coronary heart disease (CHD, defined … By design, the current review excluded studies that recruited individuals at high risk of CVD—defined
-
www.ahrq.gov/downloads/pub/evidence/pdf/bariatricrep/barirep.pdf
November 01, 2008 - is obese, and obesity is now one of the leading
causes of health-related disorders.1-12 Obesity is defined … as body mass index (BMI) of 30 kg/m2
or greater, with severe obesity defined as a BMI of 35-39.9 kg … /m,2 and morbid obesity defined as
BMI ≥ 40 kg/m.2 In general, most morbidly obese individuals are … studies
lacked the necessary design to allow for definite conclusions (i.e., patient selection not defined
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/evidence-summary-cer-199-skin-cancer.pdf
December 01, 2017 - a limited life expectancy
We excluded subpopulations based on rare genetic factors
Subgroups as defined … , 6.4) 0.9 (0.1, 6.1) 34.1 (20.0,
51.6)
0 (0, 31)
PDT (E) 17.7 (10.8, 27.8) 14.9 (5.4, 34.9) Not defined
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/hip-feature-treatment-future_research.pdf
September 23, 2010 - generally low quality of hip fracture outcome studies to date, where specific populations were
poorly defined … generally low quality
of hip fracture outcome studies to date, where specific populations were poorly defined
-
www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/inline-files/2015annlrpt%20(4)_0.pdf
January 01, 2016 - High-Priority Evidence Gaps for Clinical Preventive Services Improving the Health of Women Through Research
NOVEMBER 2015
High-Priority Evidence Gaps
For Clinical Preventive Services
IMPROVING THE HEALTH OF WOMEN THROUGH RESEARCH
SUBMITTED BY:
Dr. Albert L. Siu, Chair
Dr. Kirsten Bibbins-Domingo, Vice Chair
Dr…
-
www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/inline-files/2015annlrpt%20(4).pdf
January 01, 2016 - High-Priority Evidence Gaps for Clinical Preventive Services Improving the Health of Women Through Research
NOVEMBER 2015
High-Priority Evidence Gaps
For Clinical Preventive Services
IMPROVING THE HEALTH OF WOMEN THROUGH RESEARCH
SUBMITTED BY:
Dr. Albert L. Siu, Chair
Dr. Kirsten Bibbins-Domingo, Vice Chair
Dr…
-
www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-144-fullreport.pdf
January 01, 2020 - We defined active as having at least two
encounters at the clinic in the 2 years prior to the survey … "Full measure specifications" is defined as all information that any
potential measure implementer will
-
www.ahrq.gov/sites/default/files/2024-01/cohen-report.pdf
January 01, 2024 - and Significance
Preventable Adverse Drug Events in Community Pharmacies
Adverse drug events (ADEs), defined … The
fault trees defined thousands of pathways of process failures and behavioral elements leading to
-
effectivehealthcare.ahrq.gov/sites/default/files/product/pdf/deficit-hyperactivity-protocol.pdf
November 01, 2021 - its conduct, or interpretation differ
from the review question; or whether the target condition as defined … Pre-defined subgroups include children younger
than 7 years of age; children and adolescents, 7 through
-
effectivehealthcare.ahrq.gov/products/chronic-pain-opioid-treatment/research-protocol
-
effectivehealthcare.ahrq.gov/products/opioid-use-disorder/research-protocol
-
digital.ahrq.gov/sites/default/files/docs/citation/europe-e-prescribing-report.pdf
February 01, 2011 - 16, young people between 16 and 18 following full-
time education, people over 60, and people with defined … There
are also rigorous governance structures and defined processes for technical standards,
clinical
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/hypertension-pulmonary-arterial_executive.pdf
April 01, 2013 - 1
Comparative Effectiveness Review
Number 117
Pulmonary Arterial Hypertension:
Screening, Management, and Treatment
Executive Summary
Background
Epidemiology and Etiology of
Pulmonary Arterial Hypertension
Pulmonary arterial hypertension (PAH),
a subcategory of pulmonary hypertension
(PH), is a rare and pr…
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/r3f2G_ReqS8tN48szHPCxt
November 01, 2009 - Effects of Mammography Screening Under Different Screening Schedules: Model Estimates of Potential Benefits and Harms
Effects of Mammography Screening Under Different Screening
Schedules: Model Estimates of Potential Benefits and Harms
Jeanne S. Mandelblatt, MD, MPH; Kathleen A. Cronin, PhD; Stephanie Bailey, PhD; Do…